Physician
Cardiology
Dr. Jennifer G. Robinson, MD
|
|
Give Review
Doctor Jennifer G. Robinson, MD works in the field of Cardiology. She attended University of Minnesota Medical School. University of Minnesota Medical School is ranked 40 in research and 10 in primary care medicine She has 1 awards "CMS Meaningful Use Stage 1 Certification". Jennifer Robinson is a published physician as well. She has 96 publications published. The latest was: Counterpoint: Low-Density Lipoprotein Cholesterol Targets Are Not Needed in Lipid Treatment Guidelines.
Publications
- Guidelines for Management of Hyperlipidemia: Implications for Treatment of Patients with Stroke Secondary to Atherosclerotic Disease.
- Correlates of Successful Aging in Racial and Ethnic Minority Women Age 80 Years and Older: Findings from the Women's Health Initiative.
- The Relationship of Cardiovascular Disease to Physical Functioning in Women Surviving to Age 80 and Above in the Women's Health Initiative.
- Cardiovascular Health and Incident Cardiovascular Disease and Cancer: The Women's Health Initiative.
- Design and rationale for the Patient and Provider Assessment of Lipid Management (PALM) registry.
- Nonstatin Low-Density Lipoprotein-Lowering Therapy and Cardiovascular Risk Reduction-Statement From ATVB Council.
- Joint Associations of Diet, Lifestyle, and Genes with Age-Related Macular Degeneration.
- Atherosclerosis stabilization with PCSK-9 inhibition: An evolving concept for cardiovascular prevention.
- Emerging innovative therapeutic approaches targeting PCSK9 to lower lipids.
- Maternal lipid levels during pregnancy and gestational diabetes: a systematic review and meta-analysis.
- Statin use after acute myocardial infarction by patient complexity: are the rates right?
- Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events.
- Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events.
- Genetic Predisposition to Dyslipidemia and Risk of Preeclampsia.
- Diet Drink Consumption and the Risk of Cardiovascular Events: A Report from the Women's Health Initiative.
- Birth weight and subsequent risk of cancer.
- Comparison of lifestyle-based and traditional cardiovascular disease prediction in a multiethnic cohort of nonsmoking women.
- Efficacy and Safety of Alirocumab as Add-on Therapy in High-Cardiovascular-Risk Patients With Hypercholesterolemia Not Adequately Controlled With Atorvastatin (20 or 4...
- Contemporary evidence-based guidelines: practice based on the strongest evidence.
- Starting Primary Prevention Earlier With Statins.
- Curing Atherosclerosis Should Be the Next Major Cardiovascular Prevention Goal.
- 2013 ACC/AHA Cholesterol Guideline for Reducing Cardiovascular Risk: What is so Controversial?
- Subclinical Hypothyroidism and Risk for Incident Ischemic Stroke among Postmenopausal Women.
- Effect of evolocumab or ezetimibe added to moderate- or high-intensity statin therapy on LDL-C lowering in patients with hypercholesterolemia: the LAPLACE-2 randomized...
- Trajectories of positive aging: observations from the women's health initiative study.
- Effect of Long-Chain Ï-3 Fatty Acids and Luteinâ+âZeaxanthin Supplements on Cardiovascular Outcomes: Results of the Age-Related Eye Disease Study 2 (AREDS2) Randomized...
- Severe obesity, heart disease, and death among white, african american, and hispanic postmenopausal women.
- Geographic variation in statin use for complex acute myocardial infarction patients: evidence of effective care?
- Whole-Exome Sequencing Identifies Rare and Low-Frequency Coding Variants Associated with LDL Cholesterol.
- Association of low-frequency and rare coding-sequence variants with blood lipids and coronary heart disease in 56,000 whites and blacks.
- Higher RBC EPA + DHA corresponds with larger total brain and hippocampal volumes: WHIMS-MRI Study.
- Depressive Symptoms and Longitudinal Changes in Cognition: Women's Health Initiative Study of Cognitive Aging.
- Rationale and Design of LAPLACE-2: A Phase 3, Randomized, Double-Blind, Placebo- and Ezetimibe-Controlled Trial Evaluating the Efficacy and Safety of Evolocumab in Sub...
- Genetic Evidence for Role of Carotenoids in Age-Related Macular Degeneration in the Carotenoids in Age-Related Eye Disease Study (CAREDS).
- Omega-3 fatty acid biomarkers and subsequent depressive symptoms.
- Accumulating Evidence for Statins in Primary Prevention.
- Relationship of apolipoproteins A-1 and B, and lipoprotein(a) to cardiovascular outcomes: the AIM-HIGH Trial (Atherothrombosis Intervention in Metabolic Syndrome with ...
- Omega-3 fatty acids and domain-specific cognitive aging: Secondary analyses of data from WHISCA.
- Imputation of Coding Variants in African Americans: Better Performance using Data from the Exome Sequencing Project.
- Sleep Duration, Insomnia, and Coronary Heart Disease among Postmenopausal Women in the Women's Health Initiative.
- The rationale, design, and baseline characteristics of the Women's Health Initiative Memory Study of Younger Women (WHIMS-Y).
- Management of familial hypercholesterolemia: a review of the recommendations from the national lipid association expert panel on familial hypercholesterolemia.
- Trans-ethnic fine-mapping of lipid Loci identifies population-specific signals and allelic heterogeneity that increases the trait variance explained.
- Genetic determinants of macular pigments in women of the Carotenoids in Age-Related Eye Disease Study.
- Influence of type 2 diabetes on brain volumes and changes in brain volumes: results from the Women's Health Initiative Magnetic Resonance Imaging studies.
- Vitamin D intake and season modify the effects of the GC and CYP2R1 genes on 25-hydroxyvitamin D concentrations.
- What is the role of advanced lipoprotein analysis in practice?
- Meta-Analysis of Comparison of Effectiveness of Lowering Apolipoprotein B Versus Low-Density Lipoprotein Cholesterol and Nonhigh-Density Lipoprotein Cholesterol for Ca...
- Treatment of adults with familial hypercholesterolemia.
- Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels...
- Treatment of adults with familial hypercholesterolemia and evidence for treatment: recommendations from the National Lipid Association Expert Panel on Familial Hyperch...
- Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel ...
- Future issues, public policy, and public awareness of familial hypercholesterolemias: recommendations from the National Lipid Association Expert Panel on Familial Hype...
- Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients Clinical guidance from the National Lipid Association Expert Panel o...
- Lack of association between 25(OH)D levels and incident type 2 diabetes in older women.
- In search of self-awareness: results of the National Lipid Association 2010 Lipid Pulse membership survey.
- Fatty acid consumption and risk of fracture in the Women's Health Initiative.
- Statin use and lipid levels in older adults: National Health and Nutrition Examination Survey, 2001 to 2006.
- The cross-sectional relationship between body mass index, waist-hip ratio, and cognitive performance in postmenopausal women enrolled in the Women's Health Initiative.
- Using apolipoprotein B to manage dyslipidemia.
- Low high-density lipoprotein cholesterol and chronic disease risk marker or causal?
- Multimarker prediction of coronary heart disease risk: the Women's Health Initiative.
- Low-fat dietary pattern and lipoprotein risk factors: the Women's Health Initiative Dietary Modification Trial.
- Effect of 5 y of calcium plus vitamin D supplementation on change in circulating lipids: results from the Women's Health Initiative.
- Another treatment gap: restarting secondary prevention medications: the Women's Health Initiative.
- Are you targeting non-high-density lipoprotein cholesterol?
- Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women's Health Initiative study.
- Alcohol consumption, hypertension, and total mortality among women.
- Optimism, cynical hostility, and incident coronary heart disease and mortality in the Women's Health Initiative.
- Lipid-altering efficacy and safety of ezetimibe/simvastatin versus atorvastatin in patients with hypercholesterolemia and the metabolic syndrome (from the VYMET study).
- Meta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease risk.
- Is a statin as part of a polypill the answer?
- LDL reduction: how low should we go and is it safe?
- Cardiovascular risk in women with non-specific chest pain (from the Women's Health Initiative Hormone Trials).
- Models for describing relations among the various statin drugs, low-density lipoprotein cholesterol lowering, pleiotropic effects, and cardiovascular risk.
- Should We Use PPAR Agonists to Reduce Cardiovascular Risk?
- Safety of aggressive lipid management.
- Statin pleiotropy: a popular concept but clinical significance unclear.
- Is it time for a cardiovascular primary prevention trial in the elderly?
- Update on PPAR agonists: the clinical significance of FIELD and PROACTIVE.
- Elderly women diagnosed with nonspecific chest pain may be at increased cardiovascular risk.
- Identifying patients for aggressive cholesterol lowering: the risk curve concept.
- Antiatherosclerotic and antithrombotic effects of omega-3 fatty acids.
- Cholesterol management: targeting a lower low-density lipoprotein cholesterol concentration increases adult treatment panel-III goal attainment.
- Pleiotropic effects of statins: benefit beyond cholesterol reduction? A meta-regression analysis.
- Atorvastatin in patients with type 2 diabetes mellitus undergoing dialysis.
- A "poly-portfolio" for secondary prevention: a strategy to reduce subsequent events by up to 97% over five years.
- Comparison of effectiveness and safety of simvastatin in patients <75 versus > or =75 years of age with coronary, cerebral, or peripheral arterial disease.
- A Comparison of NCEP and Absolute Risk Stratification Methods for Lipid-Lowering Therapy in Middle-Aged Adults: The ARIC Study. The ARIC Investigators.
- Use of statins by medicare beneficiaries post myocardial infarction: poor physician quality or patient-centered care?
- Statin use and risk of haemorrhagic stroke in a community-based cohort of postmenopausal women: an observational study from the Women's Health Initiative.
- Red Blood Cell Fatty Acids and Incident Diabetes Mellitus in the Women's Health Initiative Memory Study.
- Field methods in medical record abstraction: assessing the properties of comparative effectiveness estimates.
- Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein choleste...
- Counterpoint: Low-Density Lipoprotein Cholesterol Targets Are Not Needed in Lipid Treatment Guidelines.
Schools
University of Mn Med Sch
University Minn Hospital Clins
Doctors Specialties
- Internal Medicine
- Cardiology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Minnesota at Fairview -
University of Minnesota Medical School
Helpful Reviews
Similar Doctors
|
|
Dr. Yazan Z. Hasan, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jessica E. Cyr, MD |
|
|
Dr. Michael G. Kienzle, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Diane C. Kraft, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David A. Katz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Wassef Y. Karrowni, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ankit Maheshwari, MD |
|
|
Dr. Laura I. Buck, MD |